Dopamine boosts memory for angry faces in Parkinson's disease

Movement Disorders

Volumn 25, Issue 16, 2010, Pages 2792-2799

  Subramanian, Leena ^a,b   Hindle, John Vincent ^a,b,c   Jackson, Margaret Cecilia ^a,b   Linden, David E J ^a,b,c  

^a BANGOR UNIVERSITY   (United Kingdom)

^b BANGOR UNIVERSITY   (United Kingdom)

^c BETSI CADWALADR UNIVERSITY HEALTH BOARD   (United Kingdom)

Author keywords

Dopamine; Emotion cognition interaction; Emotional faces; Parkinson's disease; Working memory

Indexed keywords

DOPAMINE;

ADULT; AGED; AROUSAL; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; EMOTIONALITY; FACIAL EXPRESSION; FEMALE; HUMAN; MALE; NEUROCHEMISTRY; PARKINSON DISEASE; PRIORITY JOURNAL; WORKING MEMORY;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIPARKINSON AGENTS; DOPAMINE; EMOTIONS; FACIAL EXPRESSION; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; PARKINSON DISEASE; PATTERN RECOGNITION, VISUAL;

EID: 78650209098     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23420     Document Type: Article

References (41)

1. Pessiglione M, Seymour B, Flandin G, Dolan RJ, Frith CD. Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 2006; 442: 1042-1045.
2. Sharot T, Shiner T, Brown AC, Fan J, Dolan RJ. Dopamine enhances expectation of pleasure in humans. Curr Biol 2009; 19: 1-4.
3. Muzerengi S, Contrafatto D, Chaudhuri KR. Non-motor symptoms: identification and management. Parkinsonism Relat Disord 2007; 13( Suppl 3): S450-S456.
4. Olanow CW, Tatton WG. Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 1999; 22: 123-144.
5. Victor M, Ropper AH. Adam and victor's principles of neurology. New York: McGraw-Hill; 2001.
6. Linden DEJ. The working memory networks of the human brain. Neuroscientist 2007; 13: 257-267.
7. Siegert RJ, Weatherall M, Taylor KD, Abernethy DA. A meta-analysis of performance on simple span and more complex working memory tasks in Parkinson's disease. Neuropsychology 2008; 22: 450-461.
8. Sprengelmeyer R, Young AW, Mahn K, Schroeder U, Woitalla D, Büttner T, Kuhn W, Przuntek H. Facial expression recognition in people with medicated and unmedicated Parkinson's disease. Neuropsychologia 2003; 41: 1047-1057.
9. Assogna F, Pontieri FE, Caltagirone C, Spalletta G. The recognition of facial emotion expressions in Parkinson's disease. Eur Neuropsychopharmacol 2008; 18: 835-848.
10. Jackson MC, Wolf C, Johnston SJ, Raymond JE, Linden DEJ. Neural correlates of enhanced visual short-term memory for angry faces: an FMRI study. PLoS One 2008; 3: e3536.
11. Gruber AJ, Dayan P, Gutkin BS, Solla SA. Dopamine modulation in the basal ganglia locks the gate to working memory. J Comput Neurosci 2006; 20: 153-66.
12. Lawrence AD, Calder AJ, McGowan SW, Grasby PM. Selective disruption of the recognition of facial expressions of anger. Neuroreport 2002; 13: 881-884.
13. Mamikonyan E, Siderowf AD, Duda JE, et al. Long-term follow up of impulse control disorders in Parkinson's disease. Mov Disord 2008; 23: 75-80.
14. Le Witt. Ropinirole, pramipexole, cabergoline vs rotigotine. Clin Neuropharmacol 2007; 30: 256-265.
15. Ekman P, Friesen WV. Pictures of facial affect. Palo Alto, CA: Consulting Psychologists Press; 1976.
16. Jackson MC, Wu CY, Linden DEJ, Raymond JE. Enhanced visual short-term memory for angry faces. J Exp Psychol Hum Percept Perform 2009; 35: 363-374.
17. Schneider WX, Eshman A, Zuccolotto A. E-Prime user's guide. Pittsburg, PA: Psychology Software Tools, Inc.; 2002.
18. Gauntlett-Gilbert J, Brown VJ. Reaction time deficits and Parkinson's disease. Neurosci Biobehav Rev 1998; 22: 865-881.
19. Bradley MM, Lang PJ. Measuring emotion: the self-assessment manikin and the semantic differential. J Behav Ther Exp Psychiatry 1994; 25: 49-59.
20. Lewis PA, Critchley HD. Mood-dependent memory. Trends Cogn Sci 2003; 7: 431-433.
21. Lawrence AD, Goerendt IK, Brooks DJ. Impaired recognition of facial expressions of anger in Parkinson's disease patients acutely withdrawn from dopamine replacement therapy. Neuropsychologia 2007; 45: 65-74.
22. Blair RJ, Morris JS, Frith CD, Perrett DI, Dolan RJ. Dissociable neural responses to facial expressions of sadness and anger. Brain 1999; 122: 883-893.
23. Harmer CJ, Thilo KV, Rothwell JC, Goodwin GM. Transcranial magnetic stimulation of medial-frontal cortex impairs the processing of angry facial expressions. Nat Neurosci 2001; 4: 17-18.
24. Williams LM, Das P, Liddell B, et al. BOLD, sweat and fears: fMRI and skin conductance distinguish facial fear signals. Neuroreport 2005; 16: 49-52.
25. Hornykiewicz O, Kish SJ. Biochemical pathophysiology of Parkinson's disease. Adv Neurol 1986; 45: 19-34.
26. Scatton B, Javoy-Agid F, Rouquier L, Dubois B, Agid Y. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res 1983; 275: 321-328.
27. Shapiro MA, Chang YL, Munson SK, Jacobson CE, Rodriguez RL, Skidmore FM, Okun MS, Fernandez HH. The four as associated with pathological Parkinson disease gamblers: anxiety, anger, age and agonists. Neuropsychiatr Dis Treat 2007; 3: 161-167.
28. Redgrave P, Gurney K. The short-latency dopamine signal: a role in discovering novel actions? Nat Rev Neurosci 2006; 7: 967-974.
29. Ji Y, Yang F, Papaleo F, et al. Role of dysbindin in dopamine receptor trafficking and cortical GABA function. Proc Natl Acad Sci USA 2009; 106: 19593-19598.
30. Del-Ben CM, Ferreira CAQ, Alves-Neto WC, Graeff FG. Serotonergic modulation of face-emotion recognition. Braz J Med Biol Res 2008; 41: 263-269.
31. Adolphs R. Fear, faces, and the human amygdale. Curr Opin Neurobiol 2008; 18: 166-172.
32. Lawrence AD, Goerendt IK, Brooks DJ. Impaired recognition of facial expressions of anger in Parkinson's disease patients acutely withdrawn from dopamine replacement therapy. Neuropsychologia 2007; 45: 65-74.
33. Leppänen JM. Emotional information processing in mood disorders: a review of behavioral and neuroimaging findings. Curr Opin Psychiatry 2006; 19: 34-39.
34. Kenealy PM. Mood-state-dependent retrieval: the effects of induced mood on memory reconsidered. Q J Exp Psychol 1997; 50A: 290-317.
35. Ridout N, Astell AJ, Reid I, Glenn T, O'Carroll R. Memory bias for emotional facial expressions in major depression. Cogn Emot 2003; 17: 101-122.
36. Jermann F, van der Linden M, D'Argembeau A. Identity recognition and happy and sad facial expression recall: influence of depressive symptoms. Memory 2008; 16: 364-373.
37. Dai Q, Feng Z. Deficient inhibition of return for emotional faces in depression. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 921-932.
38. Playfer JR, Hindle JV. Parkinson's disease in the older patient. Abingdon: Radcliffe Publishing; 2008.
39. Yamamoto M, Schapira AH. Dopamine agonists in Parkinson's disease. Expert Rev Neurother 2008; 8: 671-677.
40. Dhillon S, Yang LP, Curran MP. Spotlight on bupropion in major depressive disorder. CNS Drugs 2008; 22: 613-617.
41. Frank MJ, Seeberger LC, O'Reilly RC. By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 2004; 306: 1940-1943.